The establishment of an expected concentration reference range for eltrombopag in the individualized treatment of pediatric immune thrombocytopenia
Serum trough concentration monitoring based on the established reference ranges could enhance the precision of individualized ELT therapy in pediatric ITP patients.
Authors
- Zhifa Wang (ORCID: https://orcid.org/0000-0001-7363-5101)
- Xiaoling Cheng (ORCID: https://orcid.org/0000-0002-0048-2658)
- Jingyao Ma (ORCID: https://orcid.org/0000-0003-3737-0876)
- Shuyue Dong (ORCID: https://orcid.org/0009-0002-9282-1035)
- Xiaoling Wang (ORCID: https://orcid.org/0000-0003-2136-7410)
- Yixin Sun (ORCID: https://orcid.org/0000-0003-3487-2408)
- Runhui Wu (ORCID: https://orcid.org/0009-0007-4979-6942)
- Nan Wang (ORCID: https://orcid.org/0009-0000-7198-2505)
- Jingjing Liu (ORCID: https://orcid.org/0000-0003-0322-0087)
Institutions
- China Pharmaceutical University (CN)
- Capital Medical University (CN)
- Beijing Children’s Hospital (CN)
- Beijing Shijitan Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-08-21
- DOI
- https://doi.org/10.3389/fphar.2025.1597641
- Citations
- 1
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.77